Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 80255 BALTIMORE, MD
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$69,670,548
+$40,828,242 QoQ
Shares Held
3,825,950
+88.5% QoQ
Ownership
5.95%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 183 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. CGEM ranks #61 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in CGEM

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $69,670,548 3,825,950
2026-03-31 $28,842,306 2,029,719
2025-12-31 $488,385 47,187
2025-09-30 $256,395 43,237
2025-06-30 $274,220 36,417
2025-03-31 $240,127 31,721
2024-12-31 $359,224 29,493
2024-09-30 $428,025 25,569
2024-06-30 $362,734 20,799
2024-03-31 $389,227 22,842
2023-12-31 $224,404 22,022
2023-09-30 $130,338 14,402
2023-06-30 $154,965 14,402
2023-03-31 $143,598 14,037
2022-12-31 $148,248 14,052
2022-09-30 $174,569 13,617
2022-06-30 $150,583 11,746
2022-03-31 $116,499 11,127
2021-12-31 $163,974 10,627
2021-03-31 $30,151,745 723,584